Description:
Clinical cancer research trials are typically designed to examine the effects of a proposed intervention on the health outcome of the patients enrolled in the study. Owners commonly seek out clinical trials for pets who have failed to respond to traditional therapies or whose prognoses are poor with current standards of care. These studies often evaluate the efficacy of emerging, novel therapies for treating disease.
This session will focus on clinical research trials and how they are shaping cancer care. Dr. Antonella Borgatti - a veterinary oncologist and Director of the Clinical Investigation Center at the University of Minnesota - will create an understanding of clinical trials and highlight breakthroughs in oncology that have stemmed from clinical trials, including emerging immunotherapy approaches as well as eBAT for combatting canine hemangiosarcoma.
Dr. Mauldin will then turn the focus of discussion to some specific emerging or novel therapies showing promise for combatting cancer. He will highlight tumor vaccines and their use as an adjunct to radiotherapy for treating cancer, he will reveal some newer targets and applications of radiotherapy, a new therapy for combatting canine B-cell lymphoma (LDRHBRT), he will describe liquid fiducial markers and how they can enhance treatment outcomes, and he’ll describe the evolution of radiotherapy and some newer platforms transforming cancer care in dogs and cats.
Registration is FREE for VetVine Premium Membership subscribers.
